tiprankstipranks
Trending News
More News >
RedHill Biopharma (RDHL)
NASDAQ:RDHL
US Market
Advertisement

RedHill Biopharma (RDHL) Stock Forecast & Price Target

Compare
862 Followers
See the Price Targets and Ratings of:

RDHL Financial Forecast

RDHL Earnings Forecast

The previous quarter’s earnings for RDHL were -$2.32.
The previous quarter’s earnings for RDHL were -$2.32.

RDHL Sales Forecast

The previous quarter’s earnings for RDHL were $4.11M.
The previous quarter’s earnings for RDHL were $4.11M.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on RDHL
TR | OpenAI - 4o
TR | OpenAI - 4o
$1.5
Sell
11.11%
Upside
Reiterated
10/30/25
AI Generated ArticleAI Generated Article
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on RDHL
TR | OpenAI - 4o
TR | OpenAI - 4o
$1.5
Sell
11.11%
Upside
Reiterated
10/30/25
AI Generated ArticleAI Generated Article
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering RedHill Biopharma

1 Month
No data currently available
3 Months
No data currently available
1 Year
Bryce Generon TR | OpenAI - 4o
Success Rate
1/1 ratings generated profit
Average Return
+9.60%
reiterated a sell rating 2 days ago
Copying Bryce Generon 's trades and holding each position for 1 Year would result in - of your transactions generating a profit, with an average return of +9.60% per trade.
2 Years
No data currently available
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

RDHL Analyst Recommendation Trends

Rating
Dec 24
Jan 25
Apr 25
Jun 25
Oct 25
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
3
3
3
4
6
Sell
1
1
2
2
2
Strong Sell
0
0
0
0
0
total
4
4
5
6
8
In the current month, RDHL has received 0 Buy Ratings, 6 Hold Ratings, and 2 Sell Ratings. RDHL average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

RDHL Stock Forecast FAQ

What is RDHL’s average 12-month price target, according to analysts?
Currently, no data Available
What is RDHL’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for RDHL, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is RDHL a Buy, Sell or Hold?
      RedHill Biopharma has a consensus rating of Hold which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
        What is RedHill Biopharma’s price target?
        Currently, no data Available
        What do analysts say about RedHill Biopharma?
        RedHill Biopharma’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
          How can I buy shares of RDHL?
          Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis